Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

Pharma Investments Reflect Key Industry Trends

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.
Aug 2, 2014

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.

Risk Reduction Top Driver for Biopharmaceutical Raw Material Development

Customers are looking to reduce risk, increase performance, and optimize productivity.
Aug 2, 2014

Customers are looking to reduce risk, increase performance, and optimize productivity.

The Mainstreaming of Continuous Flow API Synthesis

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.
Jul 2, 2014

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.

Automating Online Sampling of Bioprocesses

The Modular Automated Sampling Technology platform consists of a sterile sampling system, a sample scheduler and navigator for automated sampling and delivery of samples to analytical instruments, and a data-management system.
Jul 2, 2014

The Modular Automated Sampling Technology platform allows sampling of bioreactors.

Advances in Real-Time Bioreactor Sampling

The Modular Automated Sampling Technology platform takes online samples from bioreactors and transfers them directly to analytical devices.
Jun 18, 2014

The Modular Automated Sampling Technology platform takes online samples from bioreactors and transfers them directly to analytical devices.

Alternatives to Precious Metal Catalysts Sought

Industry seeks alternatives to costly and toxic precious metals used to form the catalysts for organic synthesis.
Jun 2, 2014

Industry seeks alternatives to costly and toxic precious metals used to form the catalysts for organic synthesis.

Seeking Alternative Catalyst Solutions

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.
Jun 2, 2014

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.

HPAPIs: Fast-growing Segment Presents Challenges and Opportunities

Appropriate process design and engineering are critical for the production of small-molecule and biologic HPAPIs.
May 30, 2014

Appropriate process design and engineering are critical for the production of small-molecule and biologic HPAPIs.

Cocrystals: Industry Takes a Wait-and-See Approach

The perceived risks associated with cocrystals may be slowing progress of their industrial application.
May 30, 2014

The perceived risks associated with cocrystals may be slowing progress of their industrial application.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
9%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here